| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |